RET fusion mutation detected by re-biopsy 7 years after initial cytotoxic chemotherapy: A case report

RET fusion mutation detected by re-biopsy 7 years after initial cytotoxic chemotherapy: A case report

Personalized medicine using molecular-targeted drugs to achieve better therapeutic response and long-term prognosis is common practice for lung cancer treatment. However, in cases before gene batch tests were available, medical treatment continued without the detection of rare mutations. We report a...

Full description

Bibliographic Details
Main Authors: Kei Morikawa, Hiroshi Handa, Junko Ueno, Hajime Tsuruoka, Takeo Inoue, Naoki Shimada, Junki Koike, Seiji Nakamura, Yoshiharu Sato, Masamichi Mineshita
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Oncology
Subjects:
RET mutation detected by re-biopsy case report
gene mutation
re-biopsy
RET fusion lung cancer
selpercatinib
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1019932/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1019932/full

Similar Items